Evidence map›Paper›PMID 36217325›Full record

ArticleGynecologic oncology reports2022

Synchronous primary malignancies in ovarian cancer and liver angiosarcoma.

Tomomi Taguchi, Tomomi Egawa-Takata, Saki Kunimoto, Teruaki Nagano, Michiko Yoshimura, Kengo Haruna, Go Shinke, Yoshiaki Ohmura, Kimihiko Ito

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Gynecologic oncology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tomomi TaguchiDepartment of Obstetrics and Gynecology, Kansai Rosai Hospital, 3-1-69 Inabasou, Amagasaki Shi, Hyogo Ken, Japan.
Tomomi Egawa-TakataDepartment of Obstetrics and Gynecology, Kansai Rosai Hospital, 3-1-69 Inabasou, Amagasaki Shi, Hyogo Ken, Japan.
Saki KunimotoDepartment of Obstetrics and Gynecology, Kansai Rosai Hospital, 3-1-69 Inabasou, Amagasaki Shi, Hyogo Ken, Japan.
Teruaki NaganoDepartment of Pathology, Kansai Rosai Hospital, 3-1-69 Inabasou, Amagasaki Shi, Hyogo Ken, Japan.
Michiko YoshimuraDepartment of Pathology, Kansai Rosai Hospital, 3-1-69 Inabasou, Amagasaki Shi, Hyogo Ken, Japan.
Kengo HarunaDepartment of Surgery, Kansai Rosai Hospital, 3-1-69 Inabasou, Amagasaki Shi, Hyogo Ken, Japan.
Go ShinkeDepartment of Surgery, Kansai Rosai Hospital, 3-1-69 Inabasou, Amagasaki Shi, Hyogo Ken, Japan.
Yoshiaki OhmuraDepartment of Surgery, Kansai Rosai Hospital, 3-1-69 Inabasou, Amagasaki Shi, Hyogo Ken, Japan.
Kimihiko ItoDepartment of Obstetrics and Gynecology, Kansai Rosai Hospital, 3-1-69 Inabasou, Amagasaki Shi, Hyogo Ken, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•A case of concurrent primary ovarian clear cell adenocarcinoma and liver angiosarcoma is detailed herein.•If a liver tumor is found together with ovarian cancer, it is necessary to determine whether this is a primary hepatic malignancy or metastatic liver cancer.•It is important to make a definitive diagnosis by performing a liver biopsy when appropriate.

Indexed as

Liver angiosarcomaOvarian cancerSynchronous primary malignancies

Identifiers

PMID36217325
PMCPMC9547183

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.